Dr. Cuglievan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe blvd.
Houston, TX 77030- Is this information wrong?
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018
- Nicklaus Children's HospitalResidency, Pediatrics, 2012 - 2015
- University of San Martin de Porres Faculty of MedicineClass of 2010
- Harvard Medical SchoolCertification, Pediatrics , 2009 - 2009
- Markham CollegeIB, 2001
Certifications & Licensure
- FL State Medical License 2015 - Present
- TN State Medical License 2024 - 2026
- TX State Medical License 2018 - 2025
- OK State Medical License 2020 - 2025
- MS State Medical License 2024 - 2025
- GA State Medical License 2024 - 2025
- AL State Medical License 2024 - 2024
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Awards, Honors, & Recognition
- The President's Award for Research Excellence MD Anderson Cancer Center, 2022
- Men of Distinction Award 2020
- Excellence in Education MD Anderson Cancer Center, 2020
- Join now to see all
Clinical Trials
- Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population Start of enrollment: 2021 Sep 07
- Phase II Study to Evaluate Safety and Efficacy of CB-103 With Venetoclax in Adolescent and Young Adult Patients With Relapsed/Refractory T-ALL or T-LBL Start of enrollment: 2023 Apr 06
- Liposomal Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin for the Treatment of Relapsed Refractory Pediatric Patients With Acute Myeloid Leukemia Start of enrollment: 2021 May 21
Publications & Presentations
PubMed
- 6 citationsAplastic anemia: the correct nomenclature matters.Branko Cuglievan, April DePombo, Guillermo De Angulo
Haematologica. 2016-09-01 - 17 citationsNorth American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati
Blood. 2023-02-09 - 2 citationsEarly mortality in acute myeloid leukemia with KMT2A rearrangement is associated with high risk of bleeding and disseminated intravascular coagulation.Daniel Nguyen, Hagop M Kantarjian, Nicholas J Short, Wei Qiao, Jing Ning
Cancer. 2023-06-15
Abstracts/Posters
- New Synergistic mTOR-based combinations for the treatment of Ewing sarcoma.Menegaz BA, Cuglievan B, Admane P, Yang F, Dimiter D, Landesman Y, Lamhamedi-Cherradi SE, and Ludwig JA, AACR ( American Association for Cancer Research), Chicago, 1/1/2018
- Igf-1r/Mtor Targeted Therapy For Ewing Sarcoma: A Meta-Analysis Of Five Igf-1r-Related Trials Matched To Proteomic And Radiologic Predictive Biomarkers.Amin H, Morani A, Daw N, Lamhamedi-Cherradi S, Subbiah V, Menegaz BA, Vishwamitra D, Eskandari G, George B, Benjamin R, Patel S, Song J, Lazar A, Wang W, Kurzrock R, P..., CTOS (Connective Tissue Oncology Society), Rome, 1/1/2018
- Preclinical Efficacy of Androgen Receptor-Based Anti-Sense Therapy for the Treatment of Desmoplastic Small Round Cell Tumor.Menegaz BA, Lamhamedi-Cherradi SE, Cuglievan B, Camacho P, Kim Y, Macleod R, Hayes-Jordan A, Ludwig JA, CTOS (Connective Tissue Oncology Society), Rome, 1/1/2018
- Join now to see all
Press Mentions
- Young Acute Lymphoblastic Leukemia Survivor Benefits from Childhood Cancer ProgramsSeptember 12th, 2019
Hospital Affiliations
- University of Texas M.D. Anderson Cancer CenterHouston, Texas
- Children's Memorial Hermann HospitalHouston, Texas
- Memorial Hermann - Texas Medical CenterHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: